Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2003
12/31/2003CN1132587C Preparation method of medicine for curing surgical diseases of traditional Chinese medicine
12/31/2003CN1132586C Immunomodulating compositions from bile
12/31/2003CN1132585C Water soluble medical chitose preparation and its preparation
12/31/2003CN1132572C Mite-killing face-beauty cream
12/31/2003CA2491196A1 Materials and methods for inductions of immune tolerance
12/31/2003CA2490680A1 Allomone repulsive and kairomone attractive compositions for controlling arachnids
12/31/2003CA2490516A1 Honey-based skin care preparation
12/31/2003CA2490100A1 Pharmaceutical formulation for use in treating drug withdrawal and preparation method
12/31/2003CA2489930A1 Methods and means to promote gut absorption
12/31/2003CA2489911A1 Pasteurisation process for microbial cells and microbial oil
12/31/2003CA2489523A1 Administration of therapeutic viruses
12/31/2003CA2478508A1 Stable adenoviral vectors and methods for propagation thereof
12/30/2003US6670466 Human endogenous retrovirus in breast cancer
12/30/2003US6670397 Needed for regenerating organs or body parts, following cellular degeneration, injury or amputation; also for treating cancer and autoimmune disease; dedifferentiating cells then stabilization
12/30/2003US6670337 Administering CM101, a generally nontoxic polysaccharide isolated from group B beta -hemolytic Streptococcus (GBS) bacteria, to minimize scarring and to accelerate wound healing
12/30/2003US6670326 Depsipeptide compound
12/30/2003US6670186 RNA-loaded antigen presenting cells
12/30/2003US6670177 Infecting cells with a retrovirus in the presence of an immobilized material including a ligand which bings to the cell and a ligand which binds to the retrovirus
12/30/2003US6670146 Contacting a naive T cell with a stimulatory signal and an appropriate amount of a combination of Vitamin D3 and Dexamethasone, wherein contacting results in differentiation to a regulatory T cell
12/30/2003US6670138 Method of diagnosing ischemic stroke via UCP-2 detection
12/30/2003US6669967 Method for the treatment of symptoms related to normal hormonal variations in women
12/30/2003US6669965 Extracting aliquot of blood from subject; treating aliquot of blood ex vivo with stressor selected from oxidizing agent, ultraviolet radiation and elevated temperature; administering treated aliquot to subject
12/30/2003US6669946 Therapy; diagnosis; T cells recognize and interact with complexes of cell surface molecules such as human leukocyte antigens or major histocompatibility complexes
12/30/2003US6669944 Process for the preparation of an extract with carotenoids, UV absorption, antibacterial and pH indicating properties from a deep-sea bacterium
12/30/2003US6669943 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/30/2003US6669935 Transducing endothelial cells of arteries in brain, with genetic vectors including polynucleotides which code for cytolysis drugs; gene therapy; drug delivery
12/30/2003CA2241923C Receptor-mediated gene transfer system for targeting tumor gene therapy
12/30/2003CA2132976C Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
12/30/2003CA2090011C Anti-inflammatory factor, method of isolation, and use
12/25/2003US20030235909 Embryo cells from placenta
12/25/2003US20030235908 Adjusting lymphocyte concentration; closed container; discharging filter
12/25/2003US20030235882 Genetic engineered polypeptides; binding to antibodies
12/25/2003US20030235621 Filler mixtures comprising calcium sulfate, plasticizers and demineralized matrices
12/25/2003US20030235620 Animal extracts used as lipoxygenase inhibitors, antidiabetic, antiinflammatory, antiarthritic or antidiabetic agents; molluscs
12/25/2003US20030235592 Moraxella catarrhalis protein, gene sequence and uses thereof
12/25/2003US20030235580 Reconstituted and recombinant tissue membranes and methods for pharmaceutical delivery of bioactive molecules
12/25/2003US20030235566 Feed additives for animals: prevention of foot and mouth disease
12/25/2003US20030235563 Placental derived stem cells and uses thereof
12/25/2003US20030235562 Introducing a nucleic acid sequence encoding a lifespan extending or immortalizing protein product, under conditions such that it is expressed and a protein product is produced and engineering into a vascular graft
12/25/2003US20030235561 Vascularized organized tissues and uses thereof
12/25/2003US20030235560 Mastitis prevention
12/25/2003US20030235559 Mixing 5-70% solid food ingredient reduced to small pieces and 10-90% biocompatible liquid ingredient, adding .1-30% sugar; fermenting at 35-58 degrees c until acidity reaches 300-900 t degrees
12/25/2003US20030235557 Administering two viral vectors containing an immunogenic portion of a wilms' tumor (wt1) polynucleotide operably linked to an expression control sequence
12/24/2003WO2003106974A2 Diagnosis and treatment of chemoresistant tumors
12/24/2003WO2003106695A2 Methods and compositions for in vivo clearance of pathogens
12/24/2003WO2003106692A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/24/2003WO2003106663A1 Primarily cultured adipocytes for gene therapy
12/24/2003WO2003106662A1 In vitro fertilisation
12/24/2003WO2003106640A2 Cell targeting methods and compositions
12/24/2003WO2003106496A1 Antibodies, peptides and vaccines against hiv-1 virus
12/24/2003WO2003105908A2 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
12/24/2003WO2003105893A2 Probiotic therapies
12/24/2003WO2003105891A2 Use of hec1 antagonists in the treatment of proliferative disorders and cancer
12/24/2003WO2003105875A1 Immunostimulator having antineoplastic action and method for producing said immunostimulator
12/24/2003WO2003105874A1 Thymic epithelial cells with progenitor capacity
12/24/2003WO2003105873A1 Tailor-made preparation and process for producing the same
12/24/2003WO2003105596A1 Mammalian animal compositon
12/24/2003WO2003083080A3 Mixed- cell gene therapy
12/24/2003WO2003080813A3 Lactobacillus strains
12/24/2003WO2003075827A3 Use of mycobacterium w in the treatment of asthama(obstructive lung disease)
12/24/2003WO2003073097A9 Methods for isolating ligands e.g. t cell epitopes
12/24/2003WO2003066840A3 Pluripotent embryonic-like stem cells derived from teeth and uses thereof
12/24/2003WO2003066832A3 Generation of new insulin cells from progenitor cells present in adult pancreatic islets
12/24/2003WO2003050272A3 Bone development model
12/24/2003WO2003050251A3 Hematopoietic cells from human embryonic stem cells
12/24/2003WO2003011230A3 Modified reoviral therapy
12/24/2003WO2003009857A8 Treatment of muscular dystrophy with cord blood cells
12/24/2003WO2002102997A3 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
12/24/2003WO2002092764A3 Transgenic animal model of bone mass modulation
12/24/2003WO2001052878A8 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
12/24/2003CN1462755A Method for distilling active protein liquid of scorpion
12/24/2003CN1462635A Microzyme vaccine and bacterin for SARS epidemical tissue and its manufacturing method
12/24/2003CN1462626A Health products for improving functions of stomach intestine
12/24/2003CN1462625A ÔÇÿLingmaÔÇÖ Chinese herbal medicine wine
12/24/2003CN1462622A Method of preparing biologic calcium from snails
12/24/2003CN1462621A Formula of liquid for moist of eyes and its preparation method
12/24/2003CN1131713C Externally-applied medicine for treating nasosinusitis
12/24/2003CN1131712C Colostrinin and use thereof
12/24/2003CA2529724A1 In vitro fertilisation
12/24/2003CA2495047A1 Methods and compositions for in vivo clearance of pathogens
12/24/2003CA2489726A1 Diagnosis and treatment of chemoresistant tumors
12/24/2003CA2489296A1 Methods for the identification of allo-antigens and their use for cancer therapy and transplantation
12/24/2003CA2489292A1 Vectors for expression of hml-2 polypeptides
12/24/2003CA2487111A1 Mammalian animal composition
12/24/2003CA2479309A1 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
12/23/2003US6667176 cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
12/23/2003US6667175 Allospecific human suppressor CD8+CD28- T cells.
12/23/2003US6667174 Expression vectors containing hybrid ubiquitin promoters
12/23/2003US6667063 Nutritional or therapeutic supplement and method
12/23/2003US6667041 Use of neurotoxin therapy for treatment of urologic and related disorders
12/23/2003US6667024 Kit comprising molecule with radioisotope binding site linked to antigen-binding fragment of antibody that specifically binds to tumor associated antigen, and metal chelator and basic amino acid or peptide clearing agents
12/23/2003US6666892 Multi-formed collagenous biomaterial medical device
12/23/2003US6666842 Device and method for perfusing peritoneal dialyzing fluid
12/19/2003WO2002101076A2 Methods for targeted expression of therapeutic nucleic acid
12/19/2003CA2460095A1 Methods for targeted expression of therapeutic nucleic acid
12/19/2003CA2430889A1 Stabilization of brain natriuretic peptide (bnp) in blood samples, methods and compositions related thereto
12/18/2003WO2003104485A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
12/18/2003WO2003104467A1 Means and methods for the production of adenovirus vectors
12/18/2003WO2003104456A1 Immunomodulation using altered dendritic cells
12/18/2003WO2003104444A1 Generation of neural stem cells from undifferentiated human embryonic stem cells
1 ... 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 ... 1259